Toggle Main Menu Toggle Search

ePrints

Browsing publications by Dr Gareth Veal

Newcastle AuthorsTitleYearFull text
Dr Gareth Veal
Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence2018
Dr Marina Danilenko
Elaine Stamp
Dr Deborah Stocken
Monique Zangarini
Amy Cranston
et al.
Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib2018
Dr Britta Vormoor
Dr Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Monique Zangarini
Philip Berry
Julieann Sludden
Dr Gareth Veal
Development and validation of a LC-MS/MS method for the quantification of the checkpoint kinase 1 inhibitor SRA737 in human plasma2017
Monique Zangarini
Dr Neil Rajan
Dr Marina Danilenko
Philip Berry
Dr Gareth Veal
et al.
Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors2017
Dr Gareth Veal
Dr David Jamieson
Katja Kuver
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial2017
Dr Lindi Chen
Philip Berry
Dr Jennifer Bonner
Dr Katrina Wood
Dr Gareth Veal
et al.
In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in TP53 wild-type orthotopic models of neuroblastoma2017
Dr Gareth Veal
Carine Boue
Charlotte Lecour
Annette Otto
Maryam Rastegari
et al.
Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey2017
Dr Gareth Veal
Julie Errington
Adaptive dosing of anticancer drugs in neonates – facilitating evidence-based dosing regimens2016
Dr Gareth Veal
Julieann Sludden
Dr David Jamieson
Julie Errington
Dr Ghada Malik
et al.
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin’s lymphoma2016
123456789